Yazar "Kayabasi, C." seçeneğine göre listele
Listeleniyor 1 - 14 / 14
Sayfa Başına Sonuç
Sıralama seçenekleri
Öğe Combination of AZD3463 and salinomycin can induce apoptosis and cell cycle arrest on glioblastoma multiform cells(Nature Publishing Group, 2019) Asik, A.; Ay, N. Ozates; Bagca, B. Goker; Kayabasi, C.; Yelken, B. Ozmen; Gasimli, R.; Gunduz, C.[No abstract available]Öğe Comparative effects of Dasatinib and Ponatinib on lncRNA expression in Chronic Myeloid Leukemia(Nature Publishing Group, 2019) Kayabasi, C.; Susluer, S. Yilmaz; Okcanoglu, T. Balci; Yelken, B. Ozmen; Asik, A.; Mutlu, Z.; Gunduz, C.[No abstract available]Öğe Effect of Tumor Treating Fields and Radiotherapy Combination on Brain Tumor and Normal Brain Cell Lines(Elsevier Science Inc, 2020) Yalman, D.; Koylu, M.; Kayabasi, C.; Kamer, S.; Ozkan, E.; Yelken, B. Ozmen; Gunduz, C.[No abstract available]Öğe The effects of the different centrifugal gravities on the cell viability(Nature Publishing Group, 2019) Asik, A.; Ay, N. Ozates; Kayabasi, C.; Yelken, B. Ozmen; Sogutlu, F.; Gasimli, R.; Gunduz, C.[No abstract available]Öğe The effects of the therapeutic agents Ponatinib and VS-5584 on Chronic Myeloid Leukemia leukemogenesis(Nature Publishing Group, 2019) Kayabasi, C.; Yelken, B. Ozmen; Asik, A.; Okcanoglu, T. Balci; Sogutlu, F.; Gasimli, R.; Gunduz, C.[No abstract available]Öğe Genistein-induced apoptosis of HL-60 cells via effecting human telomerase reverse transcriptase activity(Wiley-Blackwell, 2011) Balci, T.; Avci, C. B.; Yilmaz, S.; Sigva, Z. O. D.; Yucebas, M.; Gunduz, S. N.; Kayabasi, C.; Gunduz, C.Öğe The in-vitro evaluation of anticancer effect of DMU-212, a novel resveratrol analog, on prostate cancer cells(Nature Publishing Group, 2019) Yelken, B. Ozmen; Kayabasi, C.; Asik, A.; Okcanoglu, T. Balci; Sogutlu, F.; Gasimli, R.; Gunduz, C.[No abstract available]Öğe PI3K/mTOR inhibition alters dysregulated lncRNA expression profile in leukemia stem cells and regulates downstream signaling(Wiley, 2022) Kayabasi, C.; Gunduz, C.[No Abstract Available]Öğe PKI-402 as a radiosentisizer in breast cancer cell model(Nature Publishing Group, 2019) Gasimli, R.; Kayabasi, C.; Yelken, B. Ozmen; Asik, A.; Sogutlu, F.; Celebi, C.; Gunduz, C.[No abstract available]Öğe Ponatinib inhibits breast cancer cell proliferation by regulating miRNA expressions(Wiley-Blackwell, 2014) Kayabasi, C.; Susluer, S. Yilmaz; Balci, T.; Yelken, B. Ozmen; Mutlu, Z.; Caliskan, C.; Goker, B.; Avci, C. Biray; Gunduz, C.Öğe Ponatinib regulates major signaling pathways in imatinib-resistant chronic myeloid leukemia cells(Elsevier Sci Ltd, 2013) Avci, C. Birav; Kayabasi, C.; Susluer, S. Yilmaz; Balci, T.; Saydam, G.; Baran, Y.; Gunduz, C.Öğe Profiling of apoptotic and gene expression changes in human chronic myeloid leukemia cells via transfection of mir-150 by MATRA(Wiley-Blackwell, 2013) Balci, T.; Avci, C. B.; Yilmaz, S.; Kayabasi, C.; Saydam, G.; Gunduz, C.Öğe Resveratrol promotes apoptosis, autophagy and suppressed cell division via upregulated miR-181 family and target genes in human K562 cells(Wiley-Blackwell, 2014) Mutlu, Z.; Caliskan, C.; Goker, B.; Kayabasi, C.; Sahin, F.; Saydam, G.; Gunduz, C.; Avci, C. B.Öğe VS-5584 enhances the anti-proliferative effect of ponatinib on chronic myeloid leukemia cells(Wiley, 2019) Kayabasi, C.; Yelken, B. Ozmen; Asik, A.; Okcanoglu, T. Balci; Sogutlu, F.; Gasimli, R.; Gunduz, C.[No abstract available]